ArticleGynecology and pelvic medicine2025

Durvalumab and olaparib with chemotherapy improve progression-free survival in first-line metastatic endometrial cancer: a new promising combination strategy?

Mauro Francesco Pio Maiorano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.